Mylan gets tentative USFDA nod for generic of Eli Lilly lung cancer drug Alimta Medical Dialogues Bureau31 Aug 2019 9:30 AM ISTAlimta is Lilly's third biggest-selling drug. The Indianapolis-based drugmaker reported second-quarter sales of $577.8 million for the medicine.U.S:...
Eli Lilly Vs Dr Reddys, Hospira: Court rules in favour of Lilly in Alimta alternate salt form patent lawsuit Medical Dialogues Bureau13 Aug 2019 9:15 AM ISTThe ruling came in the appeals of U.S. District Court decisions in the cases of Eli Lilly and Company v. Dr Reddy's Laboratories and Eli Lilly and...